JONI HAMBLIN: Open Payments
NPI 1376007237 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$566 in 30 payments from 9 companies in 2025. Trend: 2023 $351 · 2024 $1,017 · 2025 $566
Food & beverage: $566
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 9 | $179 |
| Indivior Inc. | 9 | $144 |
| Neurocrine BioSciences, Inc. | 4 | $77 |
| E.R. Squibb & Sons, L.L.C. | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $22 |
| Braeburn Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: LYBALVI, SUBLOCADE, INGREZZA, COBENFY, ABILIFY ASIMTUFII, MAVYRET, BRIXADI, CAPLYTA.
Industry payments across UT — which companies pay providers there.
